Ivy League Study: Boosters, COVID-19 ‘Rebounds’ Fuel Skepticism of Federal Narratives

As the nation’s most powerful and twice-boosted infectious disease doctor battles a COVID-19 “rebound” two weeks after testing positive, new research from the public health schools at Harvard and Yale suggests the boosted fared worse against the first Omicron subvariant than the non-boosted.

The FDA is so alarmed by the “waning effectiveness” of boosters, whose formulation is still based on the ancestral Wuhan strain, that it asked manufacturers Thursday to add a “spike protein component” from the fourth and fifth Omicron subvariants to this fall’s boosters.

Read More

72-year-old Congresswoman Accuses Fellow Dems of Ageism, Sexism for Picking Younger Black Male for Leadership Role

by Luke Rosiak   A 72-year-old black congresswoman accused her fellow Democratic House members of ageism and sexism after they selected a younger black male, New York Rep. Hakeem Jeffries, to lead the House Democratic Caucus on Wednesday. The caucus chairmanship is the fifth-most powerful leadership position. Unlike the hotly…

Read More